UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform... Show more
In recent trading sessions, UiPath shares have fluctuated within a narrow band near recent lows, reflecting ongoing investor caution amid rapid evolution in the artificial intelligence sector. Broader technology stocks have faced mixed sentiment due to competitive pressures from emerging AI platforms, yet UiPath’s emphasis on enterprise-grade automation has provided some support. Trading volumes have remained elevated during the latest market cycle, underscoring active interest in the company’s transition toward agentic AI solutions. Overall, the stock’s performance has tracked wider software sector trends while awaiting clearer signals from upcoming quarterly results.
Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots drawn from hundreds available across thousands of tickers. Only the strongest and most adaptable bots, based on current market conditions, strategies, timeframes, and historical performance metrics, earn placement in this section. Available bots span diverse trading styles with varying success rates, drawdowns, and win ratios, often demonstrating annualized returns in competitive ranges for suitable market environments. All bots feature unique combinations of tickers, risk parameters, and execution approaches. Investors seeking automated strategies aligned with market dynamics can explore the full selection at Trending AI Robots.
Over the past 30 days, UiPath has rolled out several product enhancements centered on agentic AI, directly influencing investor sentiment. In early May, the company released agentic AI capabilities on its Automation Suite platform, enabling more autonomous workflow execution. This was followed by the launch of UiPath for Coding Agents, which integrates coding assistance features to bridge traditional robotic process automation with generative AI tools. These updates have been viewed as positive steps toward maintaining relevance in a landscape increasingly shaped by advanced AI competitors, contributing to modest price support during periods of sector rotation.
Partnership activity has also featured prominently. On April 27, UiPath expanded its collaboration with Deloitte to integrate Test Cloud capabilities into the Ascend Platform, enhancing offerings for regulated industries. Additional alliances with Databricks and Microsoft, highlighted in late April and early May, underscore efforts to embed automation within enterprise cloud and data ecosystems. These developments have reinforced perceptions of UiPath’s execution momentum, helping limit downside pressure despite broader market concerns over AI spending.
Independent validation arrived on May 21 when UiPath was named a Leader in The Forrester Wave: Document Mining and Analytics Platforms, Q2 2026. The recognition highlighted strengths in intelligent document processing, a core growth area, and has been cited by analysts as a potential catalyst for renewed enterprise adoption.
Offsetting some positive momentum, the company announced on May 20 the passing of longtime board member S. “Soma” Somasegar, a development noted in regulatory filings but with limited immediate market impact. Looking ahead, attention has shifted to the Q1 fiscal 2027 earnings release scheduled for May 28. Consensus expectations call for revenue near $397 million and adjusted earnings per share around $0.16, with any surprises in guidance likely to drive near-term volatility. Earlier fiscal 2026 results, reported in March, showed solid beats on revenue and profitability, yet the stock has remained range-bound as investors weigh competitive dynamics and macroeconomic factors affecting IT budgets.
As UiPath enters the remainder of fiscal 2027 and beyond, investors will track progress toward the company’s stated $2 billion annualized recurring revenue target. Key themes include the pace of agentic AI adoption within large enterprises, where integration complexity and regulatory compliance remain important considerations. Management has updated long-term margin objectives, emphasizing operational efficiency alongside growth.
Competitive positioning in the expanding automation and AI software market will warrant close attention, particularly relative to pure-play generative AI providers. Cost structures, including research and development spending on new features, could influence profitability trends. Macroeconomic variables such as enterprise capital expenditure cycles and interest rate environments may also affect demand for automation solutions. Regulatory developments around data privacy and AI governance represent additional variables that could shape deployment timelines. Overall, sustained innovation in platform capabilities and successful partnership execution will remain central to long-term positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Oscillator for PATH moved out of overbought territory on June 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 instances where the indicator moved out of the overbought zone. In of the 17 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on June 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PATH as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PATH turned negative on June 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
PATH moved below its 50-day moving average on June 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PATH broke above its upper Bollinger Band on June 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for PATH crossed bullishly above the 50-day moving average on May 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.786) is normal, around the industry mean (17.156). P/E Ratio (17.050) is within average values for comparable stocks, (67.192). Projected Growth (PEG Ratio) (0.368) is also within normal values, averaging (1.756). PATH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.022). P/S Ratio (3.301) is also within normal values, averaging (138.425).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PATH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications